JENNIFER AGRUSA to Molecular Targeted Therapy
This is a "connection" page, showing publications JENNIFER AGRUSA has written about Molecular Targeted Therapy.
Connection Strength
0.192
-
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365.
Score: 0.192
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.